Hikma announces the appointment of Said Darwazah as Chief Executive Officer
The Board of Hikma Pharmaceuticals PLC announced changes to its senior management team. Said Darwazah is appointed as Chief Executive Officer with effect from 1 July 2007. Samih Darwazah, Hikma's current Chairman and Chief Executive Officer will continue in both positions until July, when he will assume the role of Non-Executive Chairman.
Said, 49, was most recently Minister of Health in the Hashemite Kingdom of Jordan, a post which he held from 2003 until 2006. From 1994 until 2003, Said was Chairman and CEO of Hikma Investment Company, then the holding company for the Hikma group. Under his leadership, the Company's facilities in Jordan, the US and Portugal were inspected and approved by the FDA. Said is currently on the Board of Directors of the Central Bank of Jordan and the King Hussein Cancer Institute. He has a degree in industrial engineering from Purdue University in the US and an MBA from INSEAD.
Most read news
Other news from the department people

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.